Please login to the form below

Not currently logged in
Email:
Password:

Next steps for former head of EMA

Dr Thomas Lönngren joins new European regulatory and market access company

Having completed his ten-year appointment as executive director of the European Medicines Agency (EMA) at the end of December 2010, Dr Thomas Lönngren has moved to the NDA Group as a strategic advisor in its newly launched business.

The company's new regulatory and market access firm, NDA Advisory Services, aims to slash rising costs and address the challenges of drug regulation and reimbursement, to ensure new medicines can get to patients faster.

Dr Lönngren will use his 30 years' experience in the regulatory field to help create a coordinated approach to Health Technology Assessment (HTA) and improve the market access situation in Europe.

"I've recognised for a long time that the whole area of market access needs new ideas and a new vision. I plan to further develop my ideas surrounding International Regulatory Strategies, coupled with pushing for a joined-up approach to HTA, to enable the best medicines to reach needy patients as efficiently as possible," he commented.

Tony Baker, vice president of the NDA Group, said: "The route to market is extremely complex and expensive and many products fail because companies do not fully address the needs to demonstrate the quality, safety and efficacy of their products and also to adapt to the European reimbursement systems. Many new drug developments terminate before they even reach the regulators. And even if a product gains approval, the industry faces great challenges over pricing and reimbursement from regional agencies. This prevents many potential groundbreaking medicines from ever reaching patients."

Meanwhile, the current head of administration at the EMA, Andreas Pott, holds the position of acting executive director while the recruitment procedure for a new executive director for the agency is completed. He has been head of administration since May 2000.

19th January 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics